Fulvestrant-Chemo Combo Targeted For ER Positive Breast Cancer

News — By on April 21, 2009 at 3:00 am

Researchers from The Cancer Institute of New Jersey (CINJ) are converging on Denver for the 100th Annual Meeting of the American Association for Cancer Research (AACR) to share their findings on a combined treatment targeting breast cancer that is stimulated by the hormone estrogen (estrogen receptive positive). They are joining other top investigators from around the globe for the event, which is highlighting interdisciplinary approaches to cancer research.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback